Dementia research
Introducing our new Director of EDoN
Mike Oldham has joined Alzheimer’s Research UK as our new Director of EDoN. We caught up with Mike to find out more about his background and the work he will be doing at Alzheimer’s Research UK. What has been your career path to date? I’m an aeronautical engineer by training, spending the first part…
When could aducanumab reach the UK?
Today is a historic day for dementia research with the US Food and Drug Administration (FDA) announcing the first (conditional) licence of a new drug for Alzheimer’s disease in a generation.
Discovering dementia drugs
At Alzheimer’s Research UK, we are committed to finding treatments that slow or stop the diseases that cause dementia.
We won’t stop until we find them.
Can we predict how dementia will progress following a diagnosis?
When someone receives a diagnosis of dementia, little is known about how their condition will progress and affect that individual over time. This is because dementia affects every person differently, with a number of factors influencing progression such as having other health conditions, our level of cognitive reserve and whether a person takes medications to treat other conditions.
Could your smartwatch hold clues to early Alzheimer’s disease?
More than a quarter of us own and use a wearable device. But what if some of the data they’re collecting could help scientists identify who was in the very early stages of a disease like Alzheimer’s, even before symptoms show?
The risk gene riddle
It turns out that risk genes are a really important piece of the puzzle that helps us build our understanding of how a disease progresses.
Celebrating the impact of dementia research volunteers
Despite delays in recruitment to face-to-face dementia research studies, volunteer enrolment onto studies hosted by Join Dementia Research is at an all-time high since the service launched in 2015.
How large DNA banks help us to make breakthroughs possible
Alzheimer’s Research UK recently awarded a £96,000 grant to Prof Kevin Morgan at the University of Nottingham to maintain and expand his large collection of DNA samples. This is to ensure he can continue his important research into the genetics of Alzheimer’s disease.
Getting dementia research back on track
Prof Katie Lunnon, the new Chair of our Grant Review Board, explains why we are urgently prioritising funding for early career dementia researchers.
Four global research highlights from 2020
It won’t come as a surprise that 2020 was a challenging year for dementia research.
But scientists have been working hard to overcome the challenges, and are continuing to make discoveries that will ultimately mean more lives free from the impact of dementia.
